LeonaBio (LONA) Amortizatization of Intangibles (2019 - 2026)
LeonaBio (LONA) reported Amortizatization of Intangibles of $74000.0 for Q1 2026, up 13.85% year-over-year from $65000.0 in Q1 2025, and up 10.45% quarter-over-quarter from $67000.0 in Q4 2025.
LeonaBio (LONA) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Amortizatization of Intangibles data on file, last reported at $74000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $74000.0, up 13.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $338000.0 (up 745.0% YoY), and the FY2025 annual result was $329000.0, up 36.51% from the prior year.
- Amortizatization of Intangibles advanced to $74000.0 in Q1 2026 per LONA's latest filing, from $67000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $686000.0 in Q2 2023 and troughed at -$917000.0 in Q4 2023.
- A 5-year average of $75294.1 and a median of $67000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 1359.57% in 2023 and fell as far as 442.16% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $268000.0 in 2022, then plunged by 442.16% to -$917000.0 in 2023, then surged by 106.87% to $63000.0 in 2024, then gained by 6.35% to $67000.0 in 2025, then grew by 10.45% to $74000.0 in 2026.
- Business Quant data shows LONA's Amortizatization of Intangibles at $74000.0 in Q1 2026, $67000.0 in Q4 2025, and $70000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Sep 30, 2025 | 70,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Jun 30, 2025 | 127,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | -253,000.00 |
| Sep 30, 2024 | -253,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | -917,000.00 |
| Dec 31, 2023 | -917,000.00 |